PA Department of Health Trainings for Clinicians and Non-Clinicians: Caring for People with Xylazine-Associated Wounds

Oct. 2024Education/Webinars

The Pennsylvania Department of Health (PA DOH) and Philadelphia Department of Public Health (PDPH), in collaboration with the Center for Forensic Science Research & Education (CSFRE), are providing virtual trainings to clinicians and non-clinicians on best practices for caring for individuals with xylazine-associated wounds. These trainings are offered at no-cost to attendees.

These trainings will be offered in two separate two-hour sessions for individuals and organizations who work in Pennsylvania. The first live webinar on Oct. 23 will be for nonclinicians and the second live webinar on Nov. 6 will be for clinicians.

Click here to register for the CLINICAL training.

*This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and Center for Forensic Science, Research and Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Penn State College of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Click here to register for the NONCLINICAL training.

*Certified Recovery Specialists (CRS) who complete this training may utilize credits to meet certification/re-certification training requirements. A training certificate will be provided to all attendees who complete the post-training assessment.

Please note: To register for a training you must create an account in CFSRE’s training platform.

Provider is responsible for verifying CME eligibility.

Recent Announcements

Voluntary nationwide recall: Tyenne (Fresenius – August 2026)

Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.
Aug. 2026Pharmacy Updates

Provider OnLine Login Changes for UPMC Employees

UPMC employees will now use their email address to access Provider OnLine. Authentication will occur through their UPMC credentials and network connections. If your UPMC email address has changed since joining the organization, you should use the email address associated with your Microsoft Teams chat account when logging in to Provider OnLine.
Aug. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Aug. 2026Education/Webinars